Patent · US Active

RHTB protein variants and the method of producing O-phosphoserine using the same

US10738091B2 · kind B2 · utility

0Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 10, 2018
Grant dateAug 11, 2020
Priority date
Expiry dateOct 10, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P13/12
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to an RhtB (homoserine/homoserine lactone export transporter) protein variant having an enhanced ability to export O-phosphoserine (OPS) that is a precursor of L-cysteine, a polynucleotide encoding the protein, a vector comprising the polynucleotide, an OPS-producing microorganism comprising the protein variant, a method of producing O-phosphoserine using the microorganism, and a method for preparing cysteine or its derivatives, which comprises reacting O-phosphoserine, produced by the method above, with a sulfide in the presence of O-phosphoserine sulfhydrylase (OPSS) or a microorganism that expresses OPSS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.